L 30 Intro to Endocrinology Flashcards
Describe the Prolactin signaling in the pituitary
Pituitary is signaled by dopamine and TRH in regards to prolactin production Dopamine decreases release TRH increases release
Bromocriptine (Parlodel) and Cabergoline
Suppress prolactin secreting tumors through dopamine agonism Cabergoline more effective and better tolerated Don’t use with pregnancy
Describe the GH axis in the pituitary
GHRH signals release
Somatostatin inhibits release
GH = somatotropin
IGF-1 mediates effects
Increases gluconeogenesis in the liver, but decreases glucose use in the periphery–favors fat use for energy
Somatotropin
Somatotrem (Protropin)
GH Agonists
Used in growth failure due to GH deficiency, renal disease, Turner’s syndrome
Cause fluid retention and edema causing papilledema and intracranial pressure
Hyperglycemia, hypothyroidism
Don’t use in DM or hypothyroidism patients
Sermorelin (Geref)
GH agonist
Synthetic GHRH
Not as effective as GH therapy
Used diagnostically
Mecasermin (Increnex)
Mecasermin rinfabate (Iplex)
Recombinant IGF-1
Not as effective as GH therapy
Used in cases where GH is no longer effective like GH receptor deletion or GH antibodies present, or when IGF-1 genes are deleted or mutated
Octreotide (Sandostatin)
Lanreotide (Somatuline)
Somatostatin agonists
Inhibits the secretion of pituitary and GI hormones
Treats GH excess–acromegaly
Also treats other hormone secreting tumors–can reduce tumor size/growth
Treats excessive diarrhea
Can cause gall stones
Pegvisomant (Somavert)
GH receptor antagonist
Used in GH excess syndromes–acromegaly
Returns IGF-1 levels to normal
May cause a GH secreting tumor from lack of feedback to the pituitary